There are 100 million couples worldwide living with infertility. In the industrial world this equals one couple out of seven. This situation is often experienced as a personal tragedy and reduced quality of life for the afflicted families.

More than 3000 fertility clinics in the world performs over 1.3 million treatments every year. Vitrolife supports fertility clinics with a complete line of effective and quality assured IVF products. We enforce industry leading quality control and use a cost effective GMP product supply infrastructure. Vitrolifes global marketing and customer support covers 80% of all IVF treatments world wide.

Transplantation

The Transplantation product area works with solutions and systems to evaluate and maintain organs outside the body in order to select usable organs and keep them in optimal condition while waiting for transplantation.

There is a world wide shortage of organ donors, leading to a mortality rate of 20-25% among people on the waiting lists for transplantation. To make things even worse, for patients in need of a lung transplant, the utilization of donor lungs is only about 15-20% from standard criteria donors.

The Vitrolife solution Perfadex significantly increases the survival rates and diminishes the risk of organ rejection in lung transplantation. It has a 95% share of the world market. With STEEN Solution the available lungs for transplantation increase more than five times. And the method will be developed further for use with other organs e.g. liver.

Stem cell therapy

Stem cell therapy has the potential to revolutionize health science and it is approaching a clinical breakthrough. Vitrolife is well positioned to become the market leader within high quality media, reagents and instruments that will facilitate the use of stem cells for therapeutic purposes. We are now focusing on development of a new clinical grade stem cell product line, xeno-free, defined and produced according to cGMP.

The company